Almenoff JS - Search Results

1

Development of a new travellers' diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy.

DuPont HL, Almenoff JS, Jamindar MS, Bortey E, Steffen R. DuPont HL, et al. Among authors: almenoff js. J Travel Med. 2023 Oct 31;30(6):taad043. doi: 10.1093/jtm/taad043. J Travel Med. 2023. PMID: 37052453 Free PMC article. Clinical Trial.

2

Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies.

Chey WD, Brenner DM, Cash BD, Hale M, Adler J, Jamindar MS, Rockett CB, Almenoff JS, Bortey E, Gudin J. Chey WD, et al. Among authors: almenoff js. J Pain Res. 2023 Aug 28;16:2943-2953. doi: 10.2147/JPR.S417045. eCollection 2023. J Pain Res. 2023. PMID: 37664485 Free PMC article.

3

Cost-Effectiveness of Vonoprazan- and Rifabutin-Based Regimens.

Almenoff J. Almenoff J. Am J Gastroenterol. 2023 Aug 1;118(8):1463-1464. doi: 10.14309/ajg.0000000000002248. Epub 2023 Apr 24. Am J Gastroenterol. 2023. PMID: 37094105 Free PMC article. No abstract available.

4

Physiologically-based pharmacokinetic modelling to predict intragastric rifabutin concentrations in the treatment of Helicobacter pylori infection.

Howden CW, Shah S, Pendse SN, Offman E, Almenoff JS, Sheldon KL. Howden CW, et al. Among authors: almenoff js. Aliment Pharmacol Ther. 2023 Jul;58(2):159-167. doi: 10.1111/apt.17526. Epub 2023 Apr 20. Aliment Pharmacol Ther. 2023. PMID: 37081832

5

Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data.

Howden CW, Sheldon KL, Almenoff JS, Chey WD. Howden CW, et al. Among authors: almenoff js. Dig Dis Sci. 2022 Sep;67(9):4382-4386. doi: 10.1007/s10620-021-07323-5. Epub 2021 Dec 4. Dig Dis Sci. 2022. PMID: 34862940 Free PMC article. Review.

6

Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.

Dove LS, Lembo A, Randall CW, Fogel R, Andrae D, Davenport JM, McIntyre G, Almenoff JS, Covington PS. Dove LS, et al. Among authors: almenoff js. Gastroenterology. 2013 Aug;145(2):329-38.e1. doi: 10.1053/j.gastro.2013.04.006. Epub 2013 Apr 9. Gastroenterology. 2013. PMID: 23583433 Free article. Clinical Trial.

7

Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience.

Vanderwall DE, Yuen N, Al-Ansari M, Bailey J, Fram D, Green DV, Pickett S, Vitulli G, Luengo JI, Almenoff JS. Vanderwall DE, et al. Among authors: almenoff js. Drug Discov Today. 2011 Aug;16(15-16):646-53. doi: 10.1016/j.drudis.2011.05.001. Epub 2011 May 11. Drug Discov Today. 2011. PMID: 21601652

8

Innovations for the future of pharmacovigilance.

Almenoff JS. Almenoff JS. Drug Saf. 2007;30(7):631-3. doi: 10.2165/00002018-200730070-00013. Drug Saf. 2007. PMID: 17604419

9

Novel statistical tools for monitoring the safety of marketed drugs.

Almenoff JS, Pattishall EN, Gibbs TG, DuMouchel W, Evans SJ, Yuen N. Almenoff JS, et al. Clin Pharmacol Ther. 2007 Aug;82(2):157-66. doi: 10.1038/sj.clpt.6100258. Epub 2007 May 30. Clin Pharmacol Ther. 2007. PMID: 17538548 Review.

10

Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.

Almenoff JS, LaCroix KK, Yuen NA, Fram D, DuMouchel W. Almenoff JS, et al. Drug Saf. 2006;29(10):875-87. doi: 10.2165/00002018-200629100-00005. Drug Saf. 2006. PMID: 16970511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters